TGTGInsighttelegram intelligenceLIVE / telegram public index
← IT news | Tg Bots

TGINSIGHT SIMILAR POSTS

유사한 콘텐츠 찾기

소스 채널 @phpdevelopersuz · Post #2421 · 4월 26일

TON hamyonining Telegram mijoziga integratsiyasi WebApp-botlari tufayli @wallet xizmati hamyonni Telegram mijozlari investitsiyalariga integratsiyalashni amalga oshirdi. Endi siz Toncoin kriptovalyutasini foydalanuvchilarga bevosita messenjerdan o‘tkazishingiz mumkin. Uzoq hamyon manzillarisiz, komissiyalarsiz va tranzaksiyani tasdiqlashni kutmasdan. Avvalroq @tginfoyozganidek, ehtimol, butun veb-bot platformasi TON Coin'ning Telegram bilan integratsiyalashuvi uchun maxsus yaratilgan. Hamyonni integratsiyalash: t.me/wallet?attach=wallet TonCoin haqida batafsil: @toncoin_uz #ton#wallet#kriptovalyuta 💚@TGraphUz | YouTube

결과

3개의 유사한 게시물이 발견되었습니다

검색: #clinicalstage

当前筛选 #clinicalstage清除筛选
Venture Village Wall 🦄

@venturevillagewall · Post #3534 · 2024. 12. 20. AM 09:31

$2.16M Fundraising by Umecrine Umecrine Cognition, a Swedish clinical-stage pharmaceutical firm, has raised $2.16 million to advance its innovative drug development targeting neurological disorders. The funding round took place on December 19, 2024. #UmecrineCognition#Pharmaceuticals#NeurologicalDisorders#Funding#Healthcare#ClinicalStage#Sweden

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 2024. 12. 21. AM 10:23

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3412 · 2024. 12. 18. PM 12:11

$60M Funding for Psioxus Psioxus Therapeutics has successfully secured $60M in funding as part of its latest round, scheduled for December 17, 2024. This funding aims to advance its innovative tumor gene therapy platform focused on improving cancer treatment outcomes. #Funding#Cancer#Biotech#Oncology#GeneTherapy#Therapeutics#ClinicalStage#Investment#Healthcare#Psioxus#AkamisBio#Tumor#LifeScience#MedicalResearch#Therapy#Innovative#Impact#Technology#Platform